Injectable nanocrystalline hydroxyapatite paste for bone substitution: in vivo analysis of biocompatibility and vascularization
Laschke MW, Witt K, Pohlemann T, Menger MD. J Biomed Mater Res B Appl Biomater. 2007 Aug;82(2):494-505

Biocompatibility testing of different sterilised or disinfected allogenous bone grafts in comparison to the gold standard of autologous bone grafts--an "in vitro" analysis of immunomodulation
Endres S, Kratz M, Heinz M, Herzberger C, Reichel S, von Garrel T, Gotzen L, Wilke A. Z Orthop Ihre Grenzgeb. 2005 Nov-Dec;143(6):660-8. German.

Biomechanical assessment of bone ingrowth in porous hydroxyapatite
Hing KA, Best SM, Tanner KE, Bonfield W, Revell PA. J Mater Sci Mater Med. 1997 Dec;8(12):731-6.

Characterization of porous hydroxyapatite
Hing KA, Best SM, Bonfield W J Mater Sci Mater Med. 1999 Mar;10(3):135-45.

Mediation of bone ingrowth in porous hydroxyapatite bone graft substitutes
Hing KA, Best SM, Tanner KE, Bonfield W, Revell PA. J Biomed Mater Res A. 2004 Jan 1;68(1):187-200.

Bone substitutes as carriers for transforming growth factor-beta(1) (TGF-beta(1))
Gille J, Dorn B, Kekow J, Bruns J, Behrens P. Int Orthop. 2002;26(4):203-6. Epub 2002 Apr 23.

Metaphyseal defect substitute: hydroxylapatite ceramic. Results of a 3 to 4 year follow up
Helber MU, Ulrich C. Unfallchirurg. 2000 Sep;103(9):749-53. German

Hydroxyapatite ceramics in clinical application. Histological findings in 23 patients
Liebendörfer A, Tröster S. Unfallchirurgie. 1997 Apr;23(2):60-8. German.

Tissue reaction and material characteristics of four bone substitutes
Jensen SS, Aaboe M, Pinholt EM, Hjørting-Hansen E, Melsen F, Ruyter IE. Int J Oral Maxillofac Implants. 1996 Jan-Feb;11(1):55-66.